XV-454

N/A

Report date: 2022/07/01 15:29:28
NME

Base Information

Drug NameXV-454
Drug Alias NameXV-454
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntegrin alpha-IIb/beta-3 antagonists
TargetsIntegrin alpha-IIb/beta-3
Therapy Area/IndicationsThrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDupont Pharmaceutical Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDupont Pharmaceutical Company
Active IndicationsN/A
Inactive IndicationsThrombosis

Other Information

ATC CodeN/A
Related LinksN/A